186 related articles for article (PubMed ID: 34638502)
1. Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index.
Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Michel M; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638502
[TBL] [Abstract][Full Text] [Related]
2. Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?
Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
Front Oncol; 2021; 11():696183. PubMed ID: 34178694
[TBL] [Abstract][Full Text] [Related]
3. Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer.
Wang W; Gu J; Liu Y; Liu X; Jiang L; Wu C; Liu J
Cancer Manag Res; 2022; 14():2803-2812. PubMed ID: 36160036
[TBL] [Abstract][Full Text] [Related]
4. Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function.
Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439116
[TBL] [Abstract][Full Text] [Related]
5. Superiority of CRP-albumin-lymphocyte index as a prognostic biomarker for patients with gastric cancer.
Zhang H; Shi J; Xie H; Liu X; Ruan G; Lin S; Ge Y; Liu C; Chen Y; Zheng X; Song M; Yang M; Zhang X; Shi HP
Nutrition; 2023 Dec; 116():112191. PubMed ID: 37716090
[TBL] [Abstract][Full Text] [Related]
6. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
7. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma.
Iida H; Tani M; Komeda K; Nomi T; Matsushima H; Tanaka S; Ueno M; Nakai T; Maehira H; Mori H; Matsui K; Hirokawa F; Kaibori M; Kubo S
HPB (Oxford); 2022 Jan; 24(1):101-115. PubMed ID: 34244053
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.
Tsai YT; Ko CA; Chen HC; Hsu CM; Lai CH; Lee YC; Tsai MS; Chang GH; Huang EI; Fang KH
J Cancer; 2022; 13(10):3000-3012. PubMed ID: 36046647
[No Abstract] [Full Text] [Related]
9. Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma.
Zou J; Yuan J; Chen H; Zhou X; Xue T; Chen R; Zhang L; Ren Z
J Gastrointest Oncol; 2022 Jun; 13(3):1376-1383. PubMed ID: 35837157
[TBL] [Abstract][Full Text] [Related]
10. The neutrophil-to-lymphocyte ratio is a predictive factor for the survival of patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Wang C; Wang M; Zhang X; Zhao S; Hu J; Han G; Liu L
Ann Transl Med; 2020 Apr; 8(8):541. PubMed ID: 32411764
[TBL] [Abstract][Full Text] [Related]
11. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
12. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
[TBL] [Abstract][Full Text] [Related]
13. Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery.
Takeda Y; Sugano H; Okamoto A; Nakano T; Shimoyama Y; Takada N; Imaizumi Y; Ohkuma M; Kosuge M; Eto K
Asian J Surg; 2024 Mar; ():. PubMed ID: 38538400
[TBL] [Abstract][Full Text] [Related]
14. Tumor Burden in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Head-to-Head Comparison of Current Scoring Systems.
Müller L; Hahn F; Auer TA; Fehrenbach U; Gebauer B; Haubold J; Zensen S; Kim MS; Eisenblätter M; Diallo TD; Bettinger D; Steinle V; Chang DH; Zopfs D; Pinto Dos Santos D; Kloeckner R
Front Oncol; 2022; 12():850454. PubMed ID: 35280804
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the C-Reactive Protein (CRP)-Albumin-Lymphocyte (CALLY) Index as a Prognostic Indicator for Patients With Gastric Cancer.
Nakashima K; Haruki K; Kamada T; Takahashi J; Tsunematsu M; Ohdaira H; Furukawa K; Suzuki Y; Ikegami T
Am Surg; 2024 Apr; ():31348241248693. PubMed ID: 38644521
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the preoperative C-reactive protein-albumin-lymphocyte (CALLY) index on outcomes after gastrectomy for gastric cancer.
Fukushima N; Masuda T; Tsuboi K; Takahashi K; Yuda M; Fujisaki M; Ikegami T; Yano F; Eto K
Surg Today; 2024 Mar; ():. PubMed ID: 38491233
[TBL] [Abstract][Full Text] [Related]
17. The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer.
Liu XY; Zhang X; Zhang Q; Ruan GT; Liu T; Xie HL; Ge YZ; Song MM; Deng L; Shi HP
Support Care Cancer; 2023 Aug; 31(9):533. PubMed ID: 37610445
[TBL] [Abstract][Full Text] [Related]
18. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study.
Wang ZX; Wang EX; Bai W; Xia DD; Mu W; Li J; Yang QY; Huang M; Xu GH; Sun JH; Li HL; Zhao H; Wu JB; Yang SF; Li JP; Li ZX; Zhang CQ; Zhu XL; Zheng YB; Wang QH; Li J; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH; On Behalf Of China Hcc-Tace Study Group
World J Gastroenterol; 2020 Feb; 26(6):657-669. PubMed ID: 32103874
[TBL] [Abstract][Full Text] [Related]
19. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
